THE SCREENING GAP
Millions of women are missing the screening that could save their lives.
Cervical cancer is largely preventable through routine HPV screening and early detection. Yet persistent barriers to clinic-based care mean the women who need screening most are the least likely to get it.
60%
Cervical cancer cases occur in women who are unscreened or under-screened
~30M
Women eligible for cervical cancer screening in the United States
2027
Federal deadline for no-cost at-home HPV screening coverage
WHY SNT BIOTECH
We do not just mail kits. We close gaps.
Historically, at-home screening programs have struggled with low completion rates - often in the single digits. We built the infrastructure that makes at-home screening actually work at population scale.
End-To-End Program Delivery
One partner, one contract kit, outreach, lab, and reporting under one accountable team.
Omni-Channel Multilingual Outreach
SMS, voice, email, and print engagement designed to earn a response, not just send one.
Owned Clia + Cola Lab
Samples processed in our own certified lab — no third party hand-offs, full chain-of custody.
Real-Time Population Health Dashboards
Live visibility into kits sent, returned, processed, and CCS gaps closed — for quality teams.
One Partner. Complete Accountability.
Integrated Program Delivery
Kit delivery, outreach, lab processing, and reporting managed through one coordinated screening partner.
Health Equity Focus
Home-based screening & multilingual engagement designed to improve access for underserved populations.
Real-Time Dashboard Visibility
Track kit status, participation, results, and care gap progress through live reporting dashboards.
Meet DiversitySpends Goal
Nationally certified minority and women-owned organization supporting supplier diversity and equity initiatives.
HOW IT WORKS
From gap identification to closed care gap.
No clinic visit required.
Deliver
FDA-cleared self-collection kit mailed directly to the member's home with serial-level tracking
Engage
Multilingual outreach via text, email, & live phone calls to drive awareness & participation
Platform
FDA-cleared self-collection kit mailed directly to the member's home with serial-level tracking
Process
BD Onclarity HPV assay with extended genotyping run at our CLIA-accredited laboratory
Report
Results delivered to the member, their PCP, & your quality team with HEDIS-ready data
THE SCREENING GAP
Bulit for Population Health Screening
Programs & Value Based Care
Supporting healthcare organizations, population health initiatives and community based screening programs through accessible at-home solutions.
Medicaid
Improve access for underserved populations.
Commercial Health Plans
Strengthen screening and engagement initiatives.
Federally Qualified Health Centers
Expand care access through community outreach.
Provider Groups
Extend screening beyond traditional settings.
DSNP Programs
Reach members with complex care needs.
Medicare Advantage
Support preventive screening participation.
Why SNT Biotech
We do not just mail kits. We close gaps.
Connect with our team to learn how home-based screening programs help improve participation and close care gaps.
ADVANCED HPV GENOTYPING
BD Onclarity Extended Genotyping
Not all HPV tests are equal. BD Onclarity identifies 14 high risk HPV types, so clinicians know exactly who needs immediate care and who can be safely monitored.
Why It Matters
Standard tests only detect HPV presence. BD Onclarity individually identifies.
GET IN TOUCH WITH US
Ready to close CCS gaps this year?
See how SNT Biotech's at-home HPV screening platform works for your member population. We will walk you through the outreach workflows, lab integration, dashboard reporting, and HEDIS data delivery.
PROVEN INFRASTRUCTURE
One Platform. Multiple Gaps in Care.
SNT Biotech has operated at-home screening programs for health plans nationally. Our platform, lab, and engagement strategies are built and battle-tested.
